The purpose of this study is to measure the effectiveness and safety of TD 4208, an
investigational drug being developed to treat people with moderate to very severe COPD,
compared to placebo, a treatment without activity.
- Subject is a male or female subject 40 years of age or older
- Females who are pregnant, lactating, breast-feeding or planning to become pregnant
during the study
Srikanth Pendyala, MD
Theravance Biopharma, US, Inc.